Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Floege

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1997
Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safetyM Burg, T Ostendorf, A Mooney, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1994
On the specificity of assays to detect circulating immunoglobulin A-fibronectin complexes: implications for the study of serologic phenomena in patients with immunoglobulin A nephropathyF Eitner, M Schulze, R Brunkhorst, et al.
Clinical and Experimental Immunology|November 1, 1991
Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokinesJ Floege, N Topley, J Hoppe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2000
Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis systemG Lonnemann, J Floege, V Kliem, et al.
Kidney International|March 1, 1992
Platelet-derived growth factor: a potentially important cytokine in glomerular diseaseR Johnson, H Iida, A Yoshimura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Amyloidosis and its relationship to different dialysersC van Ypersele de Strihou, J Floege, M Jadoul, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Minimal change nephrotic syndrome in a 74-year-old patient following parenteral administration of sheep cellsJ Floege, G Lonnemann, D O Stichtenoth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Beta 2-microglobulin kinetics during haemofiltrationJ Floege, M Wilks, S Shaldon, et al.
Experimental Nephrology|July 1, 1993
PDGF-BB, but not PDGF-AA, stimulates calcium mobilization, activation of calcium channels and cell proliferation in cultured rat mesangial cellsA Wallmon, B Fellström, R Larsson, et al.
Contributions to Nephrology|January 1, 1989
Beta-2-microglobulin and dialysis-related amyloidosis. Recent developmentsJ Floege, M F Wilks, C Granolleras, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1997
Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safetyM Burg, T Ostendorf, A Mooney, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1994
On the specificity of assays to detect circulating immunoglobulin A-fibronectin complexes: implications for the study of serologic phenomena in patients with immunoglobulin A nephropathyF Eitner, M Schulze, R Brunkhorst, et al.
Clinical and Experimental Immunology|November 1, 1991
Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokinesJ Floege, N Topley, J Hoppe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2000
Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis systemG Lonnemann, J Floege, V Kliem, et al.
Kidney International|March 1, 1992
Platelet-derived growth factor: a potentially important cytokine in glomerular diseaseR Johnson, H Iida, A Yoshimura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Amyloidosis and its relationship to different dialysersC van Ypersele de Strihou, J Floege, M Jadoul, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Minimal change nephrotic syndrome in a 74-year-old patient following parenteral administration of sheep cellsJ Floege, G Lonnemann, D O Stichtenoth, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Beta 2-microglobulin kinetics during haemofiltrationJ Floege, M Wilks, S Shaldon, et al.
Experimental Nephrology|July 1, 1993
PDGF-BB, but not PDGF-AA, stimulates calcium mobilization, activation of calcium channels and cell proliferation in cultured rat mesangial cellsA Wallmon, B Fellström, R Larsson, et al.
Contributions to Nephrology|January 1, 1989
Beta-2-microglobulin and dialysis-related amyloidosis. Recent developmentsJ Floege, M F Wilks, C Granolleras, et al.
Pageof 16